Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

NCT02987738 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type1diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Placebo Oral Tablet

Sponsor

Kinderkrankenhaus auf der Bult

Collaborators

[object Object]
[object Object]